CytoDyn Inc. reported a net loss of USD 22.6 million for the quarter ending November 30, 2025. Total interest and other expenses for the quarter amounted to USD 919 thousand. No income tax benefit was recognized during the period. Loss per share data was not disclosed in the provided information.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytoDyn Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-002335), on January 09, 2026, and is solely responsible for the information contained therein.
Comments